Arrowhead Pharmaceuticals
ARWR
#2190
Rank
C$12.31 B
Marketcap
C$87.92
Share price
-2.07%
Change (1 day)
412.60%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): C$0.50 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are C$1.09 Billion. , an increase over its 2024 earnings that were of -C$0.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 C$0.47 B-157.5%
2024 -C$0.83 Billion112.45%
2023 -C$0.39 Billion87.79%
2022 -C$0.21 Billion-20.1%
2021 -C$0.26 Billion67.59%
2020 -C$0.16 Billion-347.53%
2019 C$62.56 M-245.59%
2018 -C$42.98 Million-13.17%
2017 -C$49.5 Million-52.28%
2016 -C$0.11 Billion-16.57%
2015 -C$0.13 Billion30.32%
2014 -C$95.4 Million171.62%
2013 -C$35.13 Million16.56%
2012 -C$30.14 Million107.53%
2011 -C$14.52 Million
2008 -C$51.15 Million-8.07%
2007 -C$55.64 Million70.37%
2006 -C$32.66 Million122.51%
2005 -C$14.68 Million147.41%
2004 -C$5.94 Million2002.28%
2003 -C$0.29 Million-85.61%
2002 -C$1.97 Million1371.97%
2001 -C$0.14 Million-13.45%
2000 -C$0.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$46.24 B 9,621.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-C$3.81 Billion-899.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.22 B-52.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion-134.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$0.79 B 66.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-C$0.15 Billion-131.32%๐Ÿ‡บ๐Ÿ‡ธ USA